Why the study?
Does serum γ-glutamyl transferase (GGT) measurement identify patients with increased liver stiffness in hospitalized patients with heart failure?
Does serum γ-glutamyl transferase (GGT) measurement identify patients with increased liver stiffness in hospitalized patients with heart failure?
Routine measurement of γ-glutamyl transferase (GGT) may serve as a practical, accessible biomarker to identify heart failure patients with increased liver stiffness and complex cardiohepatic pathophysiology, particularly in HFmrEF/HFpEF.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Adachi et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: